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Planning for and managing patients who follow multidisciplinary paths allow 
institutions to provide better care administration; greater collaboration among 
medical staﬀ , patients, and their relatives; better patients education; reduced possible 
complications related to surgery and hospital stay; and increased patient adherence 
to the proposed treatments due to better information. The ERAS Society’s guidelines 
align in this direction, and many institutions are now looking to apply the suggestions 
contained in its items. This eﬀ ort is especially important in surgical oncology. In this 
work, we report the experience of our center in developing tailored guidelines for 
patients undergoing gastrectomy based on evidence from the literature and adapted to 
address the availability of personnel and equipment in our institute.
Methods:
A permanent institutional working group was established at St. Mary’s Hospital. 
Evidence‐based comprehensive research was conducted to ﬁ nd optimal perioperative 
care management for patients undergoing gastrectomy. 
Evidence and recommendations were thoroughly evaluated and considered together 
with the items from the ERAS Society’s guidelines. 
Results:
A complete patient pathway has been established from the ﬁ rst outpatient visit to 
discharge.
All ERAS items were considered and adapted to our hospital’s care environment. 
Education, nutrition, anesthesiologist care, surgical approach, and ward organization 
are the main points of strength highlighted in the present work.
Conclusion:
This proposed institutional evidence‐based protocol show comprehensive management 
for patients with gastric cancer eligible for enhanced surgical pathways.
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Background:
Gastric cancer is the second leading cause of cancer-
related death globally, and surgery is the most important 
treatment of this disease. Even so, gastric cancer surgery 
remains a high-risk procedure that is associated with 
clinically signiÀ cant postoperative stress, complications, 
and relevant sequelae. The morbidity and mortality 
of radical gastrectomy are 9.1–46.0% and 0–13%, 
respectively.
In this context, ERAS programs have been proposed 
with which to improve postoperative physiological 
functionality and facilitate patient recovery. 
ERAS protocols have many elements, including 
preoperative patient education, preoperative loading 
of carbohydrates, nutrition from the À rst postoperative 
days, early mobilization of patients, and antithrombotic 
prophylaxis.
BrieÁ y, we summarize the evidence relating to the points 
of greatest interest:
Nasal–Gastric Tube, Abdominal Drainage, Mobilization
No advantage is reported in the literature from the 
routine use of the nasogastric tube[1].
Some studies have shown that the nasogastric tube 
is not able to reduce the risk of anastomotic leakage, 
the number of lung complications, or mortality and 
that it signiÀ cantly reduces the patient’s postoperative 
comfort[2-4]. Furthermore, Yang’s meta-analysis[5] 
indicated that postoperative maintenance of the tube 
prolongs the postoperative ileum and time to À rst Á atus.
Yamada[6] reported that complications that could be 
caused by a shortening of the postoperative fasting 
period, such as pneumonia ab-ingestis or anastomotic 
leakage, did not increase in a group of patients 
undergoing ERAS. In addition, the absence of abdominal 
drainage is an additional factor that improves patient 
comfort, stimulates and facilitates walking.
The evidence does not show any beneÀ t to using 
abdominal drainage in numerous surgical procedures[7, 
8]. However, little evidence is available regarding gastric 
surgery. In particular, the use of drainages after total 
gastrectomy is still widely debated in the context of the 
development of ERAS programs.
An important item in the ERAS protocol is early 
mobilization[9], which is facilitated by absence of the 
tube and drainage as well as by early removal of the 
urinary catheter. Smart[10] has shown that failure of 
early patient mobilization is signiÀ cantly associated 
with an extension of the postoperative stay.
Several studies[6, 11-13] have shown that application 
of these points of the ERAS program can signiÀ cantly 
accelerate recovery of postoperative intestinal function 
compared with conventional management.
Nutrition
Consideration of functional outcomes such as À rst Á atus 
or resumption of peristalsis can be at risk of bias. For 
this reason, it is appropriate to analyze in more detail 
variables related to recovery of oral intake.
ERAS protocols require that the patient not be subjected 
to long periods of fasting. Early nutrition has been 
shown to reduce postoperative catabolism, accelerate 
the return of intestinal function, and reduce the risk 
of complications[14, 15]. Furthermore, Lewis et al. [16] 
conÀ rmed in their meta-analysis that keeping patients 
on an empty stomach brings no beneÀ t. Several studies 
have shown that early oral nutrition not only is feasible 
in gastric surgery but also brings signiÀ cant beneÀ ts[11, 
17]; however, this point remains controversial.
Although early resumption of feeding has been shown 
to accelerate recovery of the patient after several surgical 
procedures, use of such an approach after gastrectomy 
has historically been viewed with distrust born out of 
a concern, not well demonstrated in the literature, that 
early oral intake could cause anastomotic leakage or 
intestinal obstruction.
Over the past few years, several studies have conÀ rmed 
that early feeding after gastrectomy is safe and that it is 
associated with an improvement in functional recovery 
and a reduction in hospital stay[6, 18]. In particular, a 
randomized controlled trial reported data on safety 
in the resumption of oral feeding from the second 
postoperative day after gastrectomy[19].
Studies by Makuuchi[20] and Pedziwiatr[21], which 
contrasted use of an ERAS protocol and conventional 
management after gastrectomy, conÀ rmed that 
resumption of oral nutrition is safe from the second 
postoperative day and that it is correlated with a 
reduction in postoperative administration of Á uids 
intravenously as well as with early discharge[22].
Sugisawa[20] evaluated anastomotic leakage rate 
and pneumonia ab-ingestis to evaluate the real risk 
attributable to early nutrition. In this study, incidence 
of anastomotic leakage was 0.8% in the ERAS group—a 
À gure not only lower than that of its historical 
comparison cohort (1.7%) but also in line with or lower 
than data from previous studies reporting conventional 
perioperative management (0.8–1.9%). Hence the author 
concluded that early oral nutrition does not adversely 
affect the anastomotic site. Similar results were obtained 
by Yamada[6, 23], who showed a similar incidence in 
incidence of leaks (1.1%).
Hospital Stay
The effects of adopting an ERAS program on 
postoperative hospital stay depend not only on clinical 
factors but also on the health systems and sociocultural 
substrate of patients. For example, Yamada[6] reported 
that even though ERAS patients had a quicker functional 
recovery than those in the conventional group, length of 
stay did not signiÀ cantly differ between the two groups. 
The authors attributed this result À rst to the Japanese 
Diagnosis Procedure Combination-based Payment 
System (DPC), which allows patients to extend their 
hospitalization at a reduced cost.
Among others, Sugisawa[20] reported that the median 
of postoperative hospital stay was signiÀ cantly reduced 
in the ERAS group (8 days) compared with its historical 
cohort (10 days; p = 0.001). Similar results were 
obtained by Wang[11]. With regard to postoperative 
complications and the need for reoperation, all studies 
conÀ rmed the safety of the ERAS approach and the 
absence of any statistically signiÀ cant difference with 
the control groups[6, 20].
In conclusion, it has been widely demonstrated that 
adoption of management based on ERAS principles in 
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a reference center for gastric cancer can improve the 
patient’s functional recovery and quality of life while 
allowing early discharge[24].
We show, in the present article, the ERAS Protocol 
approved at our gastric cancer unit.
ERAS PROTOCOL
Eligibility of patients:
Each patient must meet all the inclusion criteria and 
none of the exclusion criteria:
Inclusion Criteria
• Histological diagnosis of gastric cancer
• Preoperative staging performed by EGD and/or 
endoscopic ultrasound and CT, in accordance with 
international guidelines
• Early gastric cancer (EGC)
• Advanced gastric cancer (AGC)
• Patients treated with curative intent, in accordance 
with international guidelines
Exclusion Criteria
• Distant metastasis: peritoneal carcinosis, liver 
metastases, remote lymph node metastases, 
Krukenberg tumors, involvement of other organs
• Patients at high operative risk, as deÀ ned by the 
American Society of Anesthesiologists (ASA), score 
≥ 4
• History of previous abdominal surgery for gastric 
cancer
• Synchronous malignant tumor in other organs
• Palliative surgery
Preoperative outpatient/home management:
Preoperative Counseling and Education
The meeting with the patient must take place well 
in advance of the planned intervention and/or 
hospitalization in a dedicated environment (ERAS 
outpatient clinic) stocked with easily accessible 
and readily understandable information material, 
allowing for an interview between the patient and the 
multidisciplinary team (surgeon, anesthesiologist, 
nurse, dietician). The aim is to promote compliance 
with the protocol by sharing the objectives with the 
patient and motivating him or her to adhere to the path 
outlined. To this end, family members participate in 
the preoperative interview and assist the patient both 
during the hospitalization and once they return home.
Counseling should take place sufÀ ciently in advance of 
the scheduled admission date. It is highly recommended 
that the meeting take place in a multidisciplinary manner, 
with simultaneous participation of all professionals 
involved. Doing so allows all subjects to share health 
education and information data that the patient must 
receive, while avoiding repetition and À nalizing the 
interview in an optimal way.
The anesthesiologist and surgeon should inform the 
patient of the relevant procedures and obtain informed 
consent. It is advisable that verbal information be 
integrated with delivery of informative material 
(brochures, brochures, videos, etc.).
Assessment of Respiratory
If the patient has a positive history of severe respiratory 
disease (COPD, asthma, sleep apnea syndrome), a 
clinical-instrumental evaluation of respiratory function 
is indicated, aimed at identifying subjects who could 
beneÀ t from pre- and/or postoperative respiratory 
physiotherapy.
Nutritional and Behavioral Management in the 
Preoperative Period
• Assessment of nutritional status and dietary 
prescriptions. A preoperative nutritional risk 
assessment should be performed, preferably 
using the Malnutrition Universal Screening Tool 
(MUST https://www.bapen.org.uk/screening-
and-must/must-calculator )[25, 26]. Preoperative 
administration of immunonutrition is indicated for 
at least 5 days in all patients, and at least 7 days 
in malnourished patients, before surgery. The 
dietitian’s evaluation is indicated in patients with a 
MUST score ≥ 2.
• The patient should be asked to abstain from 
smoking and intake of all alcoholic beverages.
• In the days preceding the intervention (5 days), 
the patient should follow a special diet, as outlined 
during the outpatient visit.
• The patient is hospitalized the afternoon before 
surgery and from the start of the hospitalization 
can ingest only rusk, clear liquids, and dinners 
tailored by the dietetic and nutrition service.
• The patient may not consume food during the 6–8 
h before surgery but might be able to consume 
clear liquids (clear Á uids: water, tea, coffee, sports 
drinks, meat or vegetable broth, fruit juices without 
grape/apple/blueberry pulp, popsicles without 
pulp or pieces of fruit) up to 2–4 h before surgery.
• The patient must also be instructed in how to take 
the immunonutrient mixtures per OS. The protocol 
provides for the intake of 750 mL/day of product, 
starting 5 days before surgery (7 days in the 
malnourished patient).
• Administer a maltodextrin-based drink free 
of lipids, lactose, À ber, and gluten in the 
recommended dose of 800 mL the evening before 
the intervention and then, if the intervention occurs 
in the afternoon, another in a dose of 400 mL 2–4 h 
before the intervention. The drink should be taken 
fresh and not at room temperature.
Intestinal Preparation




Administration of cefazoline 2 g IV 30 min before 
induction.






• Low doses of Midazolam ~0.05mg/kg.
Type of anesthesia:
• general balanced with vapors: sevoÁ orane or 
desÁ urane associated with continuous infusion of 
short-acting opiates such as remifentanyl
or
• totally intravenous anesthesia (TIVA TCI) with 
propofol and remifentanyl in continuous infusion 
so as to associate anesthesiological depth control 
with BIS (bispectral index) sensor
• Use of fast-metabolizing curaries such as 
cisatracurium or those that guarantee a 
total reversal of neuromuscular blockade by 
sugammadex, such as rocuronium
• Continuous monitoring with skin temperature 
sensor
• Patient skin heating systems
Intraoperative Á uid therapy optimization
• Heating of Á uids infused to the patient
• EW1000 Edwards less invasive hemodynamic 
monitoring based on pulse contour method with 
headphone sensor or intra-arterial catheter for beat-
by-beat evaluation of cardiac output (CI) and stroke 
volume (SV)
• Optimization of intraoperative Á uid therapy 
according to SV, based on the NICE protocol, 
to avoid edema of the intestinal mucosa and 
consequent slowing of motility due to overloading 
or underloading ischemias of the intestinal 
loops[27].
Intraoperative Pain and Postoperative Nausea and 
Vomiting (PONV) Control
• Transversus abdominis plane block (TAP block): 
Ropivacaine 0.2% (8-10ml/h) infused for 48-72 h 
through a multihole catheter.
• Use of Paracetamol and fans, inÀ ltration of surgical 
wounds with long-acting local anesthetics such as 
levobupivacaine or ropivacaine for pain control
• Intraoperative prevention of postoperative nausea 
and vomiting according to Apfel score[28]
• Removal of the SNG if present before the end of the 
intervention
• In the event of open interventions, inÀ ltration of the 
surgical wound with long-acting local anesthetics 
such as levobupivacaine or ropivacaine and 
placement of continuous-release catheters of local 
anesthetic at the suprafascial level.
Surgical Technique
• Surgical access: 2D/3D/4K laparoscopic, robotic-
assisted via the Da Vinci platform Yes. Laparotomic 
access is considered when the minimally invasive 
approach is not practicable.
• Drains: Not positioned in the distal gastrectomy. 
In the case of total gastrectomy, 1 drainage is 
positioned near the esophagus–jejunal anastomosis.
Postoperative management:
Immediate Postoperative Monitoring
• Transfer of the patient to recovery room
• Recovery of cognitive skills and evaluation 
according to Ramsay score
• After laparoscopic/robotic intervention continuous 
monitoring of CO2 in spontaneous breathing for 1 
h
• Pain assessment with analogue–visual VAS scale at 
5, 30, and 60 min
• Temperature control (time 0, 3 h, 6 h)
Postoperative Nausea and Vomiting (PONV)
• The goal in ERAS is not to suspend liquid intake 
and oral feeding. Optimal control of symptoms 
(nausea and vomiting) with multimodal drug 
therapy (e.g., cortisone, ondansetron) should be 
guaranteed.
• In subjects who are at high risk of PONV (assessed 
on the basis of Apfel score), anti-emetic therapy 
should be prescribed, in principle[28].
Prophylaxis of Postoperative Pain
• InÀ ltration of surgical wounds with local anesthetic
• Administration of 1 g Paracetamol IV 20 min before 
the end of the intervention, repeated 4 h and 8 h 
apart
• Targin 20 mg cpr for OS or ketorolac 30 mg IV as 
needed
Nutritional Management
SpeciÀ c nutritional protocol attached, but general 
principles include the following:
1. Preventing and/or managing malnutrition by default 
through nutritional risk assessment and gradual 
introduction of energy and nutrients until complete 
coverage needs are met.
2. Adaptation of diet to the new anotomic–functional 
capacities of the residual gastrointestinal tract and 
prevention or modulation of the different symptoms 
that can arise in the early postoperative period (sense 
of early satiety, nausea, vomiting, reÁ ux, and dumping 
syndrome) through the following:
• splitting the diet into small and frequent meals (at 
least 6 meals/day)
• Á uid intake between meals, reduced intake of foods 
and drinks rich in simple sugars due to their high 
osmotic power
• behavioral recommendations for meal 
management: eat slowly in small bites, chew well 
and sit upright for at least 30 to 60 minutes after the 
meal
Resumption of Thromboembolic Prophylaxis
Enoxaparin sodium starting from the 2nd postoperative 
day and in accordance with the guidelines.
Use of Antibiotics
Avoid if not necessary.











• Encourage patient to mobilize as early as 2 h after 
returning to the ward.
• 1st day: patient must stay out of bed for at least 8 h 
and walk at least 600 m.
• 2nd day: normal activity, not less than that 
prescribed for the 1st day.
• It is recommended that adequate rooms and 
armchairs be used to help the patient stay out 
of bed. It is useful for the patient to keep a diary 
in which to record time spent out of bed and, 
providing appropriate references, the precise 
distance walked.
Respiratory Rehabilitation Using Incentive Spirometer
1st postoperative day.
Drainage Removal
After execution of gastrograÀ n swallow (1st 
postoperative day).
Discharge criteria:
• Ability to mobilize and independently practice 
personal hygiene care
• Free diet according to nutritional indications
• Adequate pain control with oral analgesics and 
VAS score ≤ 4
• No clinical or laboratory evidence of postoperative 
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